{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:20:24Z","timestamp":1792700424032,"version":"4.5.0"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.lfs.2022.120752","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T01:58:09Z","timestamp":1656467889000},"page":"120752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":293,"special_numbering":"C","title":["Naringenin: A potential flavonoid phytochemical for cancer therapy"],"prefix":"10.1016","volume":"305","author":[{"given":"Mahzad","family":"Motallebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda Fatima","family":"Rajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Bhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Tabarraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Mohammadkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pereira-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Sadat","family":"Kasaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedeh","family":"Nouri-Majd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.B.","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia","family":"Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shakibaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bionut.2011.09.003","article-title":"Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells","volume":"1","author":"Krishnakumar","year":"2011","journal-title":"Biomedicine & Preventive Nutrition"},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/antiox8050137","article-title":"Dietary flavonoids as cancer chemopreventive agents: an updated review of human studies","volume":"8","author":"Rodr\u00edguez-Garc\u00eda","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers11010028","article-title":"Flavonoids in cancer and apoptosis","volume":"11","author":"Abotaleb","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/01635581.2015.976320","article-title":"Chemopreventive and therapeutic potential of \u201cnaringenin\u201d, a flavanone present in citrus fruits","volume":"67","author":"Mir","year":"2015","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2022.120752_bb0025","first-page":"2778","article-title":"Flavonoid: a review on naringenin","volume":"6","author":"Rao","year":"2017","journal-title":"J. Pharmacogn. Phytochem."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.nutres.2004.07.005","article-title":"Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology","volume":"24","author":"Erlund","year":"2004","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2022.120752_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lfs.2018.10.066","article-title":"Pharmacokinetic, pharmacodynamic and formulations aspects of naringenin: an update","volume":"215","author":"Joshi","year":"2018","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/pharmaceutics13020291","article-title":"Naringenin Nano-delivery systems and their therapeutic applications","volume":"13","author":"Bhia","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120752_bb0045","series-title":"Nutraceuticals and Cancer Signaling: Clinical Aspects and Mode of Action","first-page":"323","article-title":"Saffron (crocins) against cancer","author":"Bhia","year":"2021"},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0050","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/plants9121784","article-title":"Multi-therapeutic potential of naringenin (4\u2032, 5, 7-Trihydroxyflavonone): experimental evidence and mechanisms","volume":"9","author":"Arafah","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.lfs.2022.120752_bb0055","first-page":"1","article-title":"Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent","author":"Rauf","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0060","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/ptr.6781","article-title":"Naringenin, a flavanone with antiviral and anti-inflammatory effects: a promising treatment strategy against COVID-19","volume":"34","author":"Tutunchi","year":"2020","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/biom9030099","article-title":"Antidiabetic properties of naringenin: a citrus fruit polyphenol","volume":"9","author":"Den Hartogh","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2022.120752_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2017.03.042","article-title":"Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: molecular and pharmacological insights","volume":"803","author":"Nyane","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120752_bb0075","article-title":"Naringenin and naringin in cardiovascular disease prevention: a preclinical review","volume":"173535","author":"Moghaddam","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.lfs.2022.120752_bb0080","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3390\/molecules25133010","article-title":"Regulation of the mitochondrial BKCa channel by the citrus flavonoid naringenin as a potential means of preventing cell damage","volume":"25","author":"Kicinska","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0085","first-page":"413","article-title":"A comprehensive systematic review of the effects of naringenin, a citrus-derived flavonoid, on risk factors for nonalcoholic fatty liver disease","volume":"12","author":"Naeini","year":"2021","journal-title":"advancesNutrition"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1389201019666180514170122","article-title":"Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective","volume":"19","author":"Zobeiri","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0095","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.22197","article-title":"Apolipoprotein B\u2013dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin","volume":"47","author":"Nahmias","year":"2008","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.lfs.2022.120752_bb0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3748\/wjg.v24.i16.1679","article-title":"Beneficial effects of naringenin in liver diseases: molecular mechanisms","volume":"24","author":"Hern\u00e1ndez-Aquino","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/biom9110690","article-title":"On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective","volume":"9","author":"Nouri","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2022.120752_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lfs.2018.07.017","article-title":"Abd latiff, combating oxidative stress disorders with citrus flavonoid: naringenin","volume":"208","author":"Zaidun","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120752_bb0115","series-title":"A Review of the Effects of Citrus paradisi (Grapefruit) and Its Flavonoids, Naringin, and Naringenin in Metabolic Syndrome, Bioactive Food as Dietary Interventions for Diabetes","first-page":"515","author":"Razavi","year":"2019"},{"key":"10.1016\/j.lfs.2022.120752_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tifs.2018.06.012","article-title":"A recent review of citrus flavanone naringenin on metabolic diseases and its potential sources for high yield-production","volume":"79","author":"Karim","year":"2018","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.lfs.2022.120752_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570919","article-title":"Perspective: The potential effects of naringenin in COVID-19","volume":"11","author":"Alberca","year":"2020","journal-title":"Front. Immunology"},{"key":"10.1016\/j.lfs.2022.120752_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume":"146","author":"Slika","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0135","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s11010-022-04389-1","article-title":"BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression","volume":"477","author":"Xu","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12263-017-0555-5","article-title":"Food components and contaminants as (anti) androgenic molecules","volume":"12","author":"Marcoccia","year":"2017","journal-title":"Genes Nutr."},{"key":"10.1016\/j.lfs.2022.120752_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2018.08.002","article-title":"Naringenin as a potential immunomodulator in therapeutics","volume":"135","author":"Zeng","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2022.120752_bb0150","article-title":"Molecular mechanisms of action of naringenin in chronic airway diseases","volume":"173139","author":"Chin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0155","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/biom10121644","article-title":"Evaluation of naringenin as a promising treatment option for COPD based on literature review and network pharmacology","volume":"10","author":"Chen","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.118.248807","article-title":"Naringenin ameliorates radiation-induced lung injury by lowering IL-1\u03b2 level","volume":"366","author":"Zhang","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4049\/jimmunol.1900278","article-title":"Naringenin enhances the antitumor effect of therapeutic vaccines by promoting antigen cross-presentation","volume":"204","author":"Wang","year":"2020","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0170","first-page":"915","article-title":"Research updates on a novel immunomodulator, naringenin","volume":"45","author":"Wen-Feng","year":"2018","journal-title":"Prog. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0175","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.4049\/jimmunol.1602016","article-title":"Naringenin ameliorates acute inflammation by regulating intracellular cytokine degradation","volume":"199","author":"Jin","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/pharmaceutics10010033","article-title":"Hyaluronic acid decorated naringenin nanoparticles: appraisal of chemopreventive and curative potential for lung cancer","volume":"10","author":"Parashar","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13572","article-title":"Anti-inflammatory and anticancer activities of naringenin-loaded liquid crystalline nanoparticles in vitro","volume":"45","author":"Wadhwa","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.lfs.2022.120752_bb0190","first-page":"1","article-title":"Synthesis and characterization of naringenin-loaded chitosan-dextran sulfate nanocarrier","author":"Muralidharan","year":"2020","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.lfs.2022.120752_bb0195","first-page":"911","article-title":"Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics","volume":"10","author":"Ji","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.lfs.2022.120752_bb0200","first-page":"1","article-title":"Nanotechnology for delivery of natural therapeutic substances: a review","author":"Saka","year":"2020","journal-title":"Environ. Chem. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010006","article-title":"Co-delivery of letrozole and cyclophosphamide via folic acid-decorated nanoniosomes for breast cancer therapy: synergic effect, augmentation of cytotoxicity, and apoptosis gene expression","volume":"15","author":"Sahrayi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1463-1318.2003.00444.x","article-title":"The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid naringenin","volume":"5","author":"Frydoonfar","year":"2003","journal-title":"Color. Dis."},{"key":"10.1016\/j.lfs.2022.120752_bb0215","article-title":"Citrus aurantium naringenin prevents osteosarcoma progression and recurrence in the patients who underwent osteosarcoma surgery by improving antioxidant capability","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxidat. Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0220","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.apjtb.2016.08.004","article-title":"Cytotoxic, genotoxic and apoptotic effects of naringenin-oxime relative to naringenin on normal and cancer cell lines","volume":"6","author":"Kocyigit","year":"2016","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0225","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/iub.1049","article-title":"The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background","volume":"64","author":"Bulzomi","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.lfs.2022.120752_bb0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.fitote.2016.04.015","article-title":"Naringenin exerts anti-angiogenic effects in human endothelial cells: involvement of ERR\u03b1\/VEGF\/KDR signaling pathway","volume":"111","author":"Li","year":"2016","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0235","first-page":"1217","article-title":"Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and-9 activities","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0194-0","article-title":"Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer","volume":"15","author":"Abaza","year":"2015","journal-title":"Cancer Cell International"},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0245","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","article-title":"Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways","volume":"27","author":"Zhao","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1248\/bpb.28.527","article-title":"Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice","volume":"28","author":"Kanno","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0255","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3329\/bjp.v11i3.27518","article-title":"Anti-cancer effect of naringenin chalcone is mediated via the induction of autophagy, apoptosis and activation of PI3K\/Akt signalling pathway","volume":"11","author":"Zhang","year":"2016","journal-title":"Bangladesh J. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0260","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/jcmm.16226","article-title":"Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro","volume":"25","author":"Shi","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0265","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/mnfr.201000024","article-title":"Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells","volume":"55","author":"Jin","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0270","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/tox.23003","article-title":"Cytotoxicity of naringenin induces bax-mediated mitochondrial apoptosis in human lung adenocarcinoma A549 cells","volume":"35","author":"Lu","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0275","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12253-013-9641-1","article-title":"Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells","volume":"19","author":"Arul","year":"2013","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bionut.2010.06.001","article-title":"Naringenin, a flavanone alters the tumorigenic features of C6 glioma cells","volume":"1","author":"Sabarinathan","year":"2011","journal-title":"Biomed. Prevent. Nutr."},{"issue":"18","key":"10.1016\/j.lfs.2022.120752_bb0285","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.7150\/ijms.44804","article-title":"Naringenin exerts anticancer effects by inducing tumor cell death and inhibiting angiogenesis in malignant melanoma","volume":"17","author":"Choi","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110003","article-title":"Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest","volume":"9","author":"Ahamad","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0295","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3892\/etm.2015.2185","article-title":"Naringenin suppresses K562 human leukemia cell proliferation and ameliorates adriamycin-induced oxidative damage in polymorphonuclear leukocytes","volume":"9","author":"Li","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.toxlet.2006.06.005","article-title":"Naringenin-induced apoptosis via activation of NF-\u03baB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells","volume":"166","author":"Kanno","year":"2006","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0305","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.fct.2008.09.056","article-title":"Naringenin induces apoptosis through downregulation of akt and caspase-3 activation in human leukemia THP-1 cells","volume":"46","author":"Park","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0310","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/15216540400010792","article-title":"Mechanisms of naringenin-induced apoptotic Cascade in cancer cells: involvement of estrogen receptor a and \u00df signalling","volume":"56","author":"Totta","year":"2004","journal-title":"IUBMB Life"},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0315","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1007\/s13277-016-5013-2","article-title":"Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway","volume":"37","author":"Bao","year":"2016","journal-title":"Tumor Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0320","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.25729","article-title":"Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K\/AKT and MAPK signaling pathways","volume":"118","author":"Lim","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2022.120752_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2016.11.008","article-title":"Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells","volume":"99","author":"Park","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0330","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4062\/biomolther.2015.024","article-title":"Anti-proliferative effect of naringenin through p38-dependent downregulation of cyclin D1 in human colorectal cancer cells","volume":"23","author":"Song","year":"2015","journal-title":"Biomol. Ther."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0335","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/ijms19092624","article-title":"Beyond the antioxidant activity of dietary polyphenols in cancer: the modulation of estrogen receptors (ers) signaling","volume":"19","author":"Cipolletti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s13238-011-1056-8","article-title":"Naringenin reduces lung metastasis in a breast cancer resection model","volume":"2","author":"Qin","year":"2011","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0345","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3892\/etm.2016.3994","article-title":"Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and-9","volume":"13","author":"Chang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2022.120752_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2015.04.003","article-title":"Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells","volume":"235","author":"Yen","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0355","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1007\/s00044-017-1966-y","article-title":"Synthesis and antiproliferative properties of novel naringenin derivatives","volume":"26","author":"Liu","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/tox.22677","article-title":"Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms","volume":"34","author":"Chen","year":"2019","journal-title":"Environ. Toxicol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0365","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3329\/bjp.v9i3.19730","article-title":"Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases-2\/-9 via ROS\/ERK1\/2 pathways","volume":"9","author":"Lin","year":"2014","journal-title":"Bangladesh J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0370","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3892\/mmr.2014.2375","article-title":"Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP-2","volume":"10","author":"Liao","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2022.120752_bb0375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biopha.2018.07.008","article-title":"Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels","volume":"106","author":"Aktas","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0380","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.21873\/anticanres.13045","article-title":"Naringenin attenuated prostate cancer invasion via reversal of Epithelial\u2013to\u2013Mesenchymal transition and inhibited uPA activity","volume":"38","author":"Han","year":"2018","journal-title":"Anticancer Res."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050956","article-title":"Naringenin decreases invasiveness and metastasis by inhibiting TGF-\u03b2-induced epithelial to mesenchymal transition in pancreatic cancer cells","volume":"7","author":"Lou","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0390","first-page":"1144","article-title":"Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism","volume":"40","author":"Sun","year":"2015","journal-title":"China J. Chin. Mater. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/B:BREA.0000025397.56192.e2","article-title":"Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation","volume":"85","author":"Harmon","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0400","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bmcl.2012.10.130","article-title":"Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells","volume":"23","author":"Yoon","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0405","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2005.07.146","article-title":"Negative regulation of \u03b2-catenin\/Tcf signaling by naringenin in AGS gastric cancer cell","volume":"335","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.lfs.2022.120752_bb0410","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.phymed.2011.06.028","article-title":"Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt\/\u03b2-catenin signalling in mouse melanoma cells","volume":"18","author":"Huang","year":"2011","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0415","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1271\/bbb.50635","article-title":"Stimulation of melanogenesis by the citrus flavonoid naringenin in mouse B16 melanoma cells","volume":"70","author":"Ohguchi","year":"2006","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jnutbio.2005.05.009","article-title":"The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells","volume":"17","author":"Gao","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2022.120752_bb0425","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3923\/ajdd.2014.232.240","article-title":"In vitro analysis of phytochemicals epicatechin, naringenin, myricetin against Hep3B cell lines and VERO cell lines","volume":"4","author":"Sathya","year":"2014","journal-title":"Am. J. Drug Discov. Dev."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0430","first-page":"1","article-title":"Improved antioxidant, antimicrobial and anticancer activity of naringenin on conjugation with pectin","volume":"9","author":"Mundlia","year":"2019","journal-title":"3Biotech"},{"key":"10.1016\/j.lfs.2022.120752_bb0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.intimp.2015.11.036","article-title":"Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NF\u03baB and PCNA expression","volume":"30","author":"Bodduluru","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0440","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF02980179","article-title":"Suppression of CYP1A1 expression by naringenin in murine hepa-1c1c7 cells","volume":"27","author":"Kim","year":"2004","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0445","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11095-008-9793-y","article-title":"Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein","volume":"26","author":"Zhang","year":"2009","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0450","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1940-6207.CAPR-16-0209","article-title":"Targeting inflammation in cancer prevention and therapy","volume":"9","author":"Todoric","year":"2016","journal-title":"Cancer Prev. Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120752_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mce.2014.05.014","article-title":"Assessment of the proliferative capacity of the flavanones 8-prenylnaringenin, 6-(1.1-dimethylallyl) naringenin and naringenin in MCF-7 cells and the rat mammary gland","volume":"392","author":"Helle","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb0460","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/03639045.2018.1496445","article-title":"Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells","volume":"44","author":"Rajamani","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107058","article-title":"Copper (II) and 2, 2\u2032-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells","volume":"9","author":"Filho","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.120752_bb0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2015.04.011","article-title":"Insights into the mechanisms underlying the antitumor activity of an oxidovanadium (IV) compound with the antioxidant naringenin. Albumin binding studies","volume":"149","author":"Islas","year":"2015","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0475","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jsps.2020.12.002","article-title":"Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies","volume":"29","author":"Hermawan","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.lfs.2022.120752_bb0480","author":"KEGG"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-016-0698-0","article-title":"Naringenin prevents TGF-\u03b21 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation","volume":"18","author":"Zhang","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0490","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10068-010-0101-3","article-title":"Cytotoxic effects of 7-O-butyl naringenin on human breast cancer MCF-7 cells","volume":"19","author":"Park","year":"2010","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.lfs.2022.120752_bb0495","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopen.2016.09.004","article-title":"Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of naringenin in MCF-7 breast cancer cells","volume":"3","author":"Eanes","year":"2016","journal-title":"Biochimie open"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0500","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0510","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0515","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/17460441.2015.1018174","article-title":"The use of natural products in colorectal cancer drug discovery","volume":"10","author":"Miura","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.lfs.2022.120752_bb0520","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3389\/fphar.2021.699842","article-title":"Evidence that tumor microenvironment initiates epithelial-to-mesenchymal transition and calebin a can suppress it in colorectal cancer cells","volume":"12","author":"Buhrmann","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120752_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650603","article-title":"Multitargeting effects of calebin a on malignancy of CRC cells in multicellular tumor microenvironment","volume":"11","author":"Buhrmann","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0530","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/biomedicines8080236","article-title":"Targeting NF-\u03baB signaling by calebin a, a compound of turmeric, in multicellular tumor microenvironment: potential role of apoptosis induction in CRC cells","volume":"8","author":"Buhrmann","year":"2020","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.lfs.2022.120752_bb0535","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.3390\/molecules25184292","article-title":"Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study","volume":"25","author":"Buhrmann","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1291-0","article-title":"Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer","volume":"15","author":"Shakibaei","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057218","article-title":"Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-\u03baB and src protein kinase signaling pathways","volume":"8","author":"Shakibaei","year":"2013","journal-title":"PLoS One"},{"issue":"29","key":"10.1016\/j.lfs.2022.120752_bb0550","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2174\/1568026621666211105093658","article-title":"Resveratrol and colorectal cancer: a molecular approach to clinical researches","volume":"21","author":"Vernousfaderani","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0555","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4062\/biomolther.2015.024","article-title":"Anti-proliferative effect of naringenin through p38-dependent downregulation of cyclin D1 in human colorectal cancer cells","volume":"23","author":"Song","year":"2015","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.lfs.2022.120752_bb0560","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12935-015-0194-0","article-title":"Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer","volume":"15","author":"Abaza","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2022.120752_bb0565","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.09.001","article-title":"6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells","volume":"68","author":"Zhao","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0570","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1248\/bpb.28.527","article-title":"Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice","volume":"28","author":"Kanno","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0575","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4062\/biomolther.2015.109","article-title":"Naringenin-mediated ATF3 expression contributes to apoptosis in human colon cancer","volume":"24","author":"Song","year":"2016","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.lfs.2022.120752_bb0580","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.procbio.2019.05.013","article-title":"Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line","volume":"83","author":"Raeisi","year":"2019","journal-title":"Process Biochem."},{"issue":"13","key":"10.1016\/j.lfs.2022.120752_bb0585","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1080\/07391102.2019.1668301","article-title":"Formation of the inclusion complex of water soluble fluorescent calix[4]arene and naringenin: solubility, cytotoxic effect and molecular modeling studies","volume":"38","author":"Oguz","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0590","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.21622","article-title":"Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells","volume":"104","author":"Lee","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0595","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1463-1318.2003.00444.x","article-title":"The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid naringenin","volume":"5","author":"Frydoonfar","year":"2003","journal-title":"Color. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24040679","article-title":"Novel O-alkyl derivatives of naringenin and their oximes with antimicrobial and anticancer activity","volume":"24","author":"Koz\u0142owska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.120752_bb0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.procbio.2020.10.002","article-title":"Flavonoids regulate cell death-related cellular signaling via ROS in human colon cancer cells","volume":"101","author":"D\u00fckel","year":"2021","journal-title":"Process Biochem."},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb0610","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/np3003468","article-title":"Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants","volume":"75","author":"Weso\u0142owska","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0615","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1258\/ebm.2010.009359","article-title":"Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats","volume":"235","author":"Leonardi","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.lfs.2022.120752_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.104962","article-title":"4\u2032,7-Di-O-methylnaringenin (DMNG), a naringenin derivative, activates p53 signal pathway through down-regulating MDM2","volume":"89","author":"Zhang","year":"2022","journal-title":"J. Funct. Foods"},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0625","first-page":"403","article-title":"Flavanones inhibit the clonogenicity of HCT116 cololectal cancer cells","volume":"29","author":"Woo","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0630","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/tox.22528","article-title":"Ahmad ganaie, naringenin (4,5,7-trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of wistar rats","volume":"33","author":"Rehman","year":"2018","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0635","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/0008-5472.CAN-13-2245","article-title":"6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1","volume":"74","author":"Li","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0640","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.lfs.2022.120752_bb0645","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.3390\/ijms221910827","article-title":"Natural products with activity against lung cancer: a review focusing on the tumor microenvironment","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0650","first-page":"8948","article-title":"Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1\/MT1-MMP\/MMP2 pathway","volume":"8","author":"Liao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0655","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.3892\/or.2015.3889","article-title":"Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells","volume":"33","author":"Shi","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0660","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13765-012-0013-4","article-title":"Naringenin derivative diethyl (5, 4\u2032-dihydroxy flavanone-7-yl) phosphate inhibits cell growth and induces apoptosis in A549 human lung cancer cells","volume":"55","author":"Kim","year":"2012","journal-title":"J. Korean Soc. Appl. Biol. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0665","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1248\/bpb.30.2394","article-title":"Induction of apoptotic cell death by synthetic naringenin derivatives in human lung epithelial carcinoma A549 cells","volume":"30","author":"Lee","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"18","key":"10.1016\/j.lfs.2022.120752_bb0670","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1021\/jf2017594","article-title":"A synthetic naringenin derivative, 5-hydroxy-7, 4\u2032-diacetyloxyflavanone-N-phenyl hydrazone (N101\u201343), induces apoptosis through up-regulation of Fas\/FasL expression and inhibition of PI3K\/Akt signaling pathways in non-small-cell lung cancer cells","volume":"59","author":"Bak","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2022.120752_bb0675","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijbiomac.2015.03.045","article-title":"Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells","volume":"78","author":"Kumar","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0680","article-title":"Challenges in liver cancer and possible treatment approaches, biochimica et biophysica acta (BBA)-reviews on","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0685","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s40471-019-0183-2","article-title":"Environmental risk factors for liver cancer and nonalcoholic fatty liver disease","volume":"6","author":"VoPham","year":"2019","journal-title":"Curr. Epidemiol. Rep."},{"key":"10.1016\/j.lfs.2022.120752_bb0690","article-title":"Recent Progress in understanding the action of natural compounds at novel therapeutic drug targets for the treatment of liver","volume":"11","author":"Zheng","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0695","first-page":"54","article-title":"Progress and prospects of biomarkers in primary liver cancer","volume":"57","author":"Gao","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"50","key":"10.1016\/j.lfs.2022.120752_bb0700","doi-asserted-by":"crossref","first-page":"13939","DOI":"10.1021\/acs.jafc.9b05733","article-title":"6-C-(E-phenylethenyl) naringenin attenuates the stemness of hepatocellular carcinoma cells by suppressing Wnt\/\u03b2-catenin signaling","volume":"67","author":"Kang","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0705","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/09291016.2011.631764","article-title":"Attenuation of hepatocellular carcinoma by naringenin is associated with modulation of circadian rhythms of redox status in rats","volume":"43","author":"Arul","year":"2012","journal-title":"Biol. Rhythm. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0710","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09291016.2010.526417","article-title":"Protective role of naringenin on circadian rhythms of liver marker enzymes during N-nitrosodiethylamine induced hepatocarcinogenesis in rats","volume":"43","author":"Arul","year":"2012","journal-title":"Biol. Rhythm. Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0715","article-title":"Brain cancer in the world: an epidemiological review","volume":"6","author":"Farmanfarma","year":"2019","journal-title":"World Cancer Res. J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0720","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-010-0575-6","article-title":"Naringenin promote apoptosis in cerebrally implanted C6 glioma cells","volume":"345","author":"Sabarinathan","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120752_bb0725","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2010.09.028","article-title":"Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats","volume":"189","author":"Sabarinathan","year":"2011","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0730","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11010-012-1539-9","article-title":"Plausible role of naringenin against cerebrally implanted C6 glioma cells in rats","volume":"375","author":"Sabarinathan","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120752_bb0735","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/molecules22071092","article-title":"In vitro effect of 8-prenylnaringenin and naringenin on fibroblasts and glioblastoma cells-cellular accumulation and cytotoxicity","volume":"22","author":"Stompor","year":"2017","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0740","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1007\/s11033-021-06641-1","article-title":"Naringenin attenuates cell viability and migration of C6 glioblastoma cell line: a possible role of hedgehog signaling pathway","volume":"48","author":"Sargazi","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0745","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0750","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tiv.2008.12.005","article-title":"Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14\u20131, in human leukemia U937 cells","volume":"23","author":"Jin","year":"2009","journal-title":"Toxicol. in Vitro"},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb0755","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s12272-015-0624-5","article-title":"Naringenin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt\u2019s lymphoma cells","volume":"38","author":"Kim","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0760","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/ijms20092184","article-title":"Synthesis and in vitro antitumor activity of naringenin oxime and oxime ether derivatives","volume":"20","author":"Latif","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0765","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.11.001","article-title":"Skin cancer and new treatment perspectives: a review","volume":"357","author":"Sim\u00f5es","year":"2015","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0770","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.3390\/molecules190811679","article-title":"Review of natural compounds for potential skin cancer treatment","volume":"19","author":"Chinembiri","year":"2014","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0775","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/01635581.2019.1656756","article-title":"Naringenin suppresses chemically induced skin cancer in two-stage skin carcinogenesis mouse model","volume":"72","author":"Kumar","year":"2020","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2022.120752_bb0780","article-title":"The anti-zika virus and anti-tumoral activity of the citrus flavanone lipophilic naringenin-based compounds","volume":"331","author":"de Oliveira Mendes","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.120752_bb0785","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lfs.2015.11.030","article-title":"Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells","volume":"144","author":"Bouzaiene","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120752_bb0790","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jep.2015.08.015","article-title":"Inhibitory effect of GB-2a (I3-naringenin-II8-eriodictyol) on melanogenesis","volume":"174","author":"Campos","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0795","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.currproblcancer.2018.06.003","article-title":"Cervical cancer worldwide","volume":"42","author":"Vu","year":"2018","journal-title":"Curr. Probl. Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0800","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/15216540400010792","article-title":"Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling","volume":"56","author":"Totta","year":"2004","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0805","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bionut.2011.09.003","article-title":"Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells","volume":"1","author":"Krishnakumar","year":"2011","journal-title":"Biomedicine and Perventive Nutr."},{"issue":"7","key":"10.1016\/j.lfs.2022.120752_bb0810","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800016","article-title":"Synthesis, cancer-selective antiproliferative and apoptotic effects of some (\u00b1)-naringenin cycloaminoethyl derivatives","volume":"15","author":"Zaim","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0815","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tiv.2011.10.012","article-title":"The apoptotic effects of the flavonoid N101\u20132 in human cervical cancer cells","volume":"26","author":"Kim","year":"2012","journal-title":"Toxicol. in Vitro"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0820","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"issue":"17\u201318","key":"10.1016\/j.lfs.2022.120752_bb0825","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/biomedicines8080281","article-title":"Targeting mutant kras in pancreatic cancer: futile or promising?","volume":"8","author":"Nollmann","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2022.120752_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.11.022","article-title":"Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway","volume":"58","author":"Lee","year":"2019","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0840","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nutres.2007.12.002","article-title":"Naringenin reduces tumor size and weight lost in N-methyl-N\u2032-nitro-N-nitrosoguanidine\u2013induced gastric carcinogenesis in rats","volume":"28","author":"Ekambaram","year":"2008","journal-title":"Nutr. Res."},{"issue":"10","key":"10.1016\/j.lfs.2022.120752_bb0845","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1440-1681.2008.04987.x","article-title":"Modulatory effect of naringenin on n-methyl-n\u2032-nitro-n-nitrosoguanidine-and saturated sodium chloride-induced gastric carcinogenesis in male wistar rats","volume":"35","author":"Ganapathy","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0850","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/ijms22052252","article-title":"New insights into oral squamous cell carcinoma: from clinical aspects to molecular tumorigenesis","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0855","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/ijms23031562","article-title":"Proliferation and apoptosis pathways and factors in oral squamous cell carcinoma","volume":"23","author":"He","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2022.120752_bb0860","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/nu5072564","article-title":"Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies","volume":"5","author":"Iriti","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2022.120752_bb0865","first-page":"1","article-title":"Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration","author":"Kawaguchi","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2022.120752_bb0870","first-page":"1","article-title":"Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells","volume":"e14221","author":"Liu","year":"2022","journal-title":"J. Food Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0875","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/07357907.2020.1768401","article-title":"Epidemiology and risk factors of osteosarcoma","volume":"38","author":"Sadykova","year":"2020","journal-title":"Cancer Investig."},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb0880","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911131","article-title":"Sarcoma treatment in the era of molecular medicine","volume":"12","author":"Gr\u00fcnewald","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0885","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12938-021-00860-0","article-title":"Osteosarcoma: a review of current and future therapeutic approaches","volume":"20","author":"Zhao","year":"2021","journal-title":"Biomed. Eng. Online"},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb0890","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s11655-019-2941-x","article-title":"Anticancer effects of constituents of herbs targeting osteosarcoma","volume":"25","author":"Su","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.lfs.2022.120752_bb0895","doi-asserted-by":"crossref","first-page":"8713263","DOI":"10.1155\/2018\/8713263","article-title":"Citrus aurantium naringenin prevents osteosarcoma progression and recurrence in the patients who underwent osteosarcoma surgery by improving antioxidant capability","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0900","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/molecules27020373","article-title":"Naringenin induces ROS-mediated ER stress, autophagy, and apoptosis in human osteosarcoma cell lines","volume":"27","author":"Lee","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb0905","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"issue":"19","key":"10.1016\/j.lfs.2022.120752_bb0910","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0915","first-page":"167","article-title":"Puerarin inhibits bladder cancer cell proliferation through the mTOR\/p70S6K signaling pathway","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb0920","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/cas.14334","article-title":"Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway","volume":"111","author":"Iida","year":"2020","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0925","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/medicines5030087","article-title":"Anticancer effects of green tea and the underlying molecular mechanisms in bladder cancer","volume":"5","author":"Miyata","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.lfs.2022.120752_bb0930","series-title":"Seminars in Oncology Nursing","first-page":"151","article-title":"Ovarian cancer: an integrated review","author":"Stewart","year":"2019"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.lfs.2022.120752_bb0940","article-title":"Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration, cancer immunology","author":"Kawaguchi","year":"2022","journal-title":"Immunotherapy"},{"issue":"8","key":"10.1016\/j.lfs.2022.120752_bb0945","first-page":"312","article-title":"Improved antioxidant, antimicrobial and anticancer activity of naringenin on conjugation with pectin, 3","volume":"9","author":"Mundlia","year":"2019","journal-title":"Biotech"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020373","article-title":"Naringenin induces ROS-mediated ER stress, autophagy, and apoptosis in human osteosarcoma cell lines","volume":"27","author":"Lee","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.120752_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105264","article-title":"Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review","volume":"171","author":"Memariani","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb0960","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yexcr.2014.05.017","article-title":"A naringenin\u2013tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells","volume":"327","author":"Hatkevich","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb0965","first-page":"1703","article-title":"Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin: systematic approach for improved breast cancer therapeutics, nanomedicine: nanotechnology","volume":"13","author":"Sandhu","year":"2017","journal-title":"Biol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb0970","first-page":"122","article-title":"Naringenin enhances the anti-cancer effect of cyclophosphamide against MDA-MB-231 breast cancer cells via targeting the STAT3 signaling pathway","volume":"19","author":"Noori","year":"2020","journal-title":"Iranian J. Pharm. Res."},{"key":"10.1016\/j.lfs.2022.120752_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173725","article-title":"Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo","volume":"891","author":"Pateliya","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120752_bb0980","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2016.07.007","article-title":"Hesperetin and naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors","volume":"160","author":"Chandrika","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb0985","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.3762\/bjoc.11.297","article-title":"Physical properties and biological activities of hesperetin and naringenin in complex with methylated \u03b2-cyclodextrin","volume":"11","author":"Sangpheak","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb0990","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.ymthe.2018.06.016","article-title":"Combination of asiatic acid and naringenin modulates NK cell anti-cancer immunity by rebalancing Smad3\/Smad7 signaling","volume":"26","author":"Lian","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2022.120752_bb0995","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omto.2021.01.006","article-title":"Inhibition of tumor invasion and metastasis by targeting TGF-\u03b2-smad-MMP2 pathway with asiatic acid and naringenin","volume":"20","author":"Lian","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb1000","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10637-020-00979-2","article-title":"Glioma progression is suppressed by naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo","volume":"38","author":"Song","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb1005","first-page":"1","article-title":"Diosmin in combination with naringenin enhances apoptosis in colon cancer cells","volume":"47","author":"Zeya","year":"2022","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2022.120752_bb1010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/01635581.2021.1952438","article-title":"Combinatorial effect of temozolomide and naringenin in human glioblastoma multiforme cell lines","volume":"74","author":"Gautam","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"sup3","key":"10.1016\/j.lfs.2022.120752_bb1015","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1080\/21691401.2018.1505738","article-title":"Biotinylated naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum metabolomics","volume":"46","author":"Parashar","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb1020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/01635581.2012.686648","article-title":"Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo","volume":"64","author":"Anand","year":"2012","journal-title":"Nutr. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2022.120752_bb1025","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.3892\/mmr.2015.4480","article-title":"Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways","volume":"12","author":"Shi","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb1030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/01635581.2017.1328605","article-title":"Denatonium and naringenin promote SCA-9 tumor growth and angiogenesis: participation of arginase","volume":"69","author":"Dmytrenko","year":"2017","journal-title":"Nutr. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb1035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/etm.2015.2912","article-title":"Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb1040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/iub.279","article-title":"Naringenin and 17\u03b2-estradiol coadministration prevents hormone-induced human cancer cell growth","volume":"62","author":"Bulzomi","year":"2010","journal-title":"IUBMB Life"},{"issue":"7","key":"10.1016\/j.lfs.2022.120752_bb1045","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/01635581.2014.951732","article-title":"Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro","volume":"66","author":"Maggioni","year":"2014","journal-title":"Nutr. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb1050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10534-015-9894-0","article-title":"Copper (II) complexes with naringenin and hesperetin: cytotoxic activity against a 549 human lung adenocarcinoma cells and investigation on the mode of action","volume":"29","author":"Tamayo","year":"2016","journal-title":"Biometals"},{"key":"10.1016\/j.lfs.2022.120752_bb1055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2016.07.007","article-title":"Hesperetin and naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors","volume":"160","author":"Chandrika","year":"2016","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.lfs.2022.120752_bb1060","first-page":"1703","article-title":"Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin: systematic approach for improved breast cancer therapeutics, nanomedicine: nanotechnology","volume":"13","author":"Sandhu","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.lfs.2022.120752_bb1065","article-title":"Anti-inflammation and anti-cancer effects of naringenin combination with artemisinins in human lung cancer cells","volume":"26","author":"Amelimojarad","year":"2022","journal-title":"Gene Rep."},{"key":"10.1016\/j.lfs.2022.120752_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128580","article-title":"A review on biosynthesis of metal nanoparticles and its environmental applications","volume":"264","author":"Saravanan","year":"2021","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb1075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J. Nanotechnol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb1080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03639045.2020.1747485","article-title":"Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies","volume":"46","author":"Akhter","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.lfs.2022.120752_bb1085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/ph13070152","article-title":"Formulation design, statistical optimization, and in vitro evaluation of a naringenin nanoemulsion to enhance apoptotic activity in a549 lung cancer cells","volume":"13","author":"Md","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.lfs.2022.120752_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2020.104480","article-title":"Cysteine conjugated chitosan based green nanohybrid hydrogel embedded with zinc oxide nanoparticles towards enhanced therapeutic potential of naringenin","volume":"148","author":"George","year":"2020","journal-title":"React. Funct. Polym."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb1095","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/nano10040718","article-title":"Improving anticancer therapy with naringenin-loaded silk fibroin nanoparticles","volume":"10","author":"Fuster","year":"2020","journal-title":"Nanomaterials"},{"issue":"12","key":"10.1016\/j.lfs.2022.120752_bb1100","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.3390\/ijms21124557","article-title":"Naringenin-functionalized multi-walled carbon nanotubes: a potential approach for site-specific remote-controlled anticancer delivery for the treatment of lung cancer cells","volume":"21","author":"Morais","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2022.120752_bb1105","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/ma14092142","article-title":"Novel polymeric biomaterial based on naringenin","volume":"14","author":"Latos-Brozio","year":"2021","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.lfs.2022.120752_bb1110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-013-1715-6","article-title":"Screening of chemopreventive effect of naringenin-loaded nanoparticles in DMBA-induced hamster buccal pouch carcinogenesis by FT-IR spectroscopy","volume":"382","author":"Krishnakumar","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2022.120752_bb1115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.saa.2013.05.076","article-title":"Raman spectroscopic investigation of the chemopreventive response of naringenin and its nanoparticles in DMBA-induced oral carcinogenesis","volume":"115","author":"Krishnakumar","year":"2013","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"4","key":"10.1016\/j.lfs.2022.120752_bb1120","doi-asserted-by":"crossref","DOI":"10.1088\/1054-660X\/23\/4\/045601","article-title":"Evaluation of the chemopreventive response of naringenin-loaded nanoparticles in experimental oral carcinogenesis using laser-induced autofluorescence spectroscopy","volume":"23","author":"Sulfikkarali","year":"2013","journal-title":"Laser Phys."},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb1125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12253-012-9581-1","article-title":"Chemopreventive efficacy of naringenin-loaded nanoparticles in 7, 12-dimethylbenz (a) anthracene induced experimental oral carcinogenesis","volume":"19","author":"Sulfikkarali","year":"2013","journal-title":"Pathol. Oncol. Res."},{"issue":"11","key":"10.1016\/j.lfs.2022.120752_bb1130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2217\/nnm-2016-0436","article-title":"Oral naringenin nanocarriers: fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments","volume":"12","author":"Chaurasia","year":"2017","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2022.120752_bb1135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.xphs.2017.10.006","article-title":"Potential of cationic-polymeric nanoparticles for oral delivery of naringenin: in vitro and in vivo investigations","volume":"107","author":"Chaurasia","year":"2018","journal-title":"J. Pharm. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:00:55Z","timestamp":1758402055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522004520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":227,"alternative-id":["S0024320522004520"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120752","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringenin: A potential flavonoid phytochemical for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120752"}}